Key result
Dermatomyositis is linked to a ~45% higher prevalence of LV diastolic dysfunction versus healthy controls.
Why the study?
Is dermatomyositis associated with subclinical left ventricular diastolic dysfunction in patients without evident cardiovascular disease?
Case-Control (n=102)
Yes
Is dermatomyositis associated with subclinical left ventricular diastolic dysfunction in patients without evident cardiovascular disease?
Absolute Event Rate: 76.5% vs 52.9%
p-value: p=<0.05
Patients with dermatomyositis have a high frequency of subclinical left ventricular diastolic dysfunction, which correlates with disease duration.
May indicate subclinical LV diastolic dysfunction in dermatomyositis; hypothesis-generating and should not yet change practice.
OBJECTIVE: To assess left ventricular (LV) diastolic function in patients with dermatomyositis (DM) without clinically evident cardiovascular (CV) disease and to estimate whether there is an association between the duration of DM and LV diastolic dysfunction (LVDD). METHODS: The study included 51 patients with DM (43 women and 8 men) who had no clinically evident CV disease and 51 age-matched and sex-matched healthy controls. Echocardiographic and Doppler studies were conducted in all patients and controls. Early diastolic flow velocity/mitral annular early diastolic velocity (E/Em) was considered a marker for diastolic dysfunction. RESULTS: E/Em was elevated in 39 patients (76.5%) versus 27 controls (52.9%; p < 0.05). There were significant differences between patients versus control group in late diastolic flow velocity (A), E/A ratio, Em, Em/Am (mitral annular late diastolic velocity) ratio, E/Em ratio, and deceleration time (DT; p < 0.05). There was a weak correlation with disease duration between A (r = 0.373, p = 0.007), E/A ratio (r = -0.467, p = 0.001), Em (r = -0.474, p < 0.001), Em/Am ratio (r = -0.476, p < 0.001), E/Em ratio (r = 0.320, p = 0.022), and DT (r = 0.474, p < 0.001). Disease duration was associated with E/Em after controlling for age, sex, and other factors (p < 0.05). CONCLUSION: Our study confirms a high frequency of LVDD in DM patients without evident CV disease. The association between transmitral flow alteration and disease duration may suggest a subclinical myocardial involvement with disease progression.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) conducted a case-control in Dermatomyositis without clinically evident cardiovascular disease (n=102). Dermatomyositis vs. Healthy controls was evaluated on Elevated early diastolic flow velocity/mitral annular early diastolic velocity (E/Em) ratio (>8) as a marker for diastolic dysfunction (p=<0.05). Dermatomyositis was associated with a significantly higher frequency of left ventricular diastolic dysfunction compared to healthy controls (76.5% vs 52.9%, p < 0.05).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: